Ollie's SVP/CIO converts 3,159 options to shares and sells under 10b5-1
Rhea-AI Filing Summary
Ollie's Bargain Outlet Holdings, Inc. (OLLI) reported insider transactions by SVP & CIO Larry Kraus on 10/06/2025. The filing shows exercise of 3,159 employee stock options (aggregate of grants with strike prices of $43.21, $57.98, and $86.03) and contemporaneous sales of the same 3,159 shares under a Rule 10b5-1 plan adopted on 07/07/2025. Proceeds from the sales were reported at weighted average prices in the range near $131 per share, and the reporting person’s beneficial ownership following the transactions is shown as 3,679 shares held directly. The transactions were executed pursuant to a written trading plan and were reported by an attorney-in-fact on 10/08/2025.
Positive
- Transactions executed under a Rule 10b5-1 plan adopted on 07/07/2025, indicating pre-planned timing
- Exercised options converted to shares (3,159 shares), reflecting realization of compensation rather than new grant issuance
- Filing discloses vesting schedules for grants through 03/23/2027, providing transparency on future option vesting
Negative
- Insider sold 3,159 shares, reducing immediate direct economic exposure to the company's stock
- Sales occurred at weighted average prices near $131, which may indicate significant monetization at current market levels
Insights
TL;DR: Insider exercised vested options and sold the resulting shares under a 10b5-1 plan on 10/06/2025.
The reporting person exercised 3,159 stock options across three grants with exercise prices of $43.21, $57.98, and $86.03, and sold the same number of shares under a Rule 10b5-1 plan adopted on 07/07/2025. This pattern—exercise then sale via an approved plan—is a common mechanism for monetizing vested equity while aiming to mitigate insider trading risk.
Key dependencies and near-term items to watch include any future scheduled vesting (remaining option tranches noted in the filing) and whether additional 10b5-1 plans are adopted or amended; the filing discloses vesting schedules with installments through 03/25/2026 for certain grants.
TL;DR: The transactions convert vested option value into cash at weighted-average sale prices near $131 per share.
The exercised options converted into 3,159 common shares and were immediately sold at weighted average prices reported in the filing (ranges cited around $130.51–$131.50). The filing also details historical grant sizes and vesting: grants from 03/22/2021, 03/25/2022, and 03/23/2023 with staggered 25% annual vesting.
Monitor the remaining unvested/vested option counts and the reporting person’s post-transaction direct ownership of 3,679 shares to assess future dilution and potential future sales when further tranches vest (notably through 03/23/2027 for some grants).
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) | 2,559 | $0.00 | -- |
| Exercise | Employee Stock Option (right to buy) | 500 | $0.00 | -- |
| Exercise | Employee Stock Option (right to buy) | 100 | $0.00 | -- |
| Exercise | Common Stock, par value $0.001 per share | 2,559 | $43.21 | $111K |
| Sale | Common Stock, par value $0.001 per share | 2,559 | $131.55 | $337K |
| Exercise | Common Stock, par value $0.001 per share | 500 | $57.98 | $29K |
| Sale | Common Stock, par value $0.001 per share | 500 | $131.02 | $66K |
| Exercise | Common Stock, par value $0.001 per share | 100 | $86.03 | $9K |
| Sale | Common Stock, par value $0.001 per share | 100 | $131.40 | $13K |
Footnotes (1)
- Transactions made pursuant to an agreement adopted on July 7, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The price reported in column 4 is the price at which these shares were sold in a single transaction. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.51-131.44, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.27-131.50, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Options vest and become exercisable in 25% installments on each anniversary date of the grant, March 25, 2022, subject to continued service through each applicable vesting date. The reporting person was granted 10,236 options, of which 2,559 vested on March 25, 2023; 2,559 vested on March 25, 2024; 2,559 vested on March 25, 2025; and 2,559 vest on March 25, 2026. Options vest and become exercisable in 25% installments on each anniversary date of the grant, March 23, 2023, subject to continued service through each applicable vesting date. The reporting person was granted 6,866 options, of which 1,717 vested on March 23, 2024; 1,716 vested on March 23, 2025; 1,717 vest on March 23, 2026; and 1,716 vest on March 23, 2027. Options vest and become exercisable in 25% installments on each anniversary date of the grant, March 22, 2021, subject to continued service through each applicable vesting date. The reporting person was granted 4,634 options, and the options vested in their entirely on March 22, 2025.
FAQ
What did OLLI insider Larry Kraus do on 10/06/2025?
What were the exercise prices for the options exercised by the OLLI insider?
When was the 10b5-1 plan adopted for these trades?
